In Industry News

Last month the EMA published the new good pharmacovigilance practice (GVP) chapter IV.

This chapter has specific considerations for the paediatric population addressing the needs and challenges of safety monitoring of medicines used in children.

See more here:

For the full Guideline on good pharmacovigilance practices (GVP) see here:

Recent Posts